(R)-4-(2-Hydroxyethyl)-2,2-dimethyl-1,3-dioxolane>94.0%(GC)1g

5-Bromo-1-chloro-3-fluoro-2-isopropoxybenzene, 98%, 250mg

Bispyribac, 97%, 100g

5-(tert-Butyl)nicotinic acid, 95.0%, 1g

Methyl 3-(5-amino-1,3,4-thiadiazol-2-yl)propanoate, 95%, 5g

3-Nitrobenzotrifluoride>96.0%(GC)500g

N-(2-aminoethyl)-2-(5-(3-phenoxyphenyl)-2H-tetrazol-2-yl)acetamide, 98%, 1g

3-Bromo-5-nitro-1-methyl-1H-indazole, 97.0%, 1g

1-(Difluoromethyl)-2,3,4,5,6-pentafluorobenzene, 5g

Sulfacetamide>98.0%(HPLC)(T)25g

1-(4-methoxybenzyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 1g

(1R,2S,5S)-6,6-Dimethyl-3-[(2-methylpropan-2-yl)oxycarbonyl]-3-azabicyclo[3.1.0]hexane-2-carboxylic acid, 97%, 250mg

4-(4,5-Dihydro-4,4-dimethyloxazol-2-yl)aniline, 95.0%, 5g